1. Home
  2. IRON vs SBR Comparison

IRON vs SBR Comparison

Compare IRON & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRON
  • SBR
  • Stock Information
  • Founded
  • IRON 2017
  • SBR 1982
  • Country
  • IRON United States
  • SBR United States
  • Employees
  • IRON N/A
  • SBR N/A
  • Industry
  • IRON Biotechnology: Pharmaceutical Preparations
  • SBR Oil & Gas Production
  • Sector
  • IRON Health Care
  • SBR Energy
  • Exchange
  • IRON Nasdaq
  • SBR Nasdaq
  • Market Cap
  • IRON 1.9B
  • SBR 932.9M
  • IPO Year
  • IRON N/A
  • SBR N/A
  • Fundamental
  • Price
  • IRON $57.83
  • SBR $66.34
  • Analyst Decision
  • IRON Strong Buy
  • SBR
  • Analyst Count
  • IRON 10
  • SBR 0
  • Target Price
  • IRON $73.70
  • SBR N/A
  • AVG Volume (30 Days)
  • IRON 245.9K
  • SBR 46.3K
  • Earning Date
  • IRON 11-12-2024
  • SBR 01-01-0001
  • Dividend Yield
  • IRON N/A
  • SBR 8.28%
  • EPS Growth
  • IRON N/A
  • SBR 5.15
  • EPS
  • IRON N/A
  • SBR 6.49
  • Revenue
  • IRON N/A
  • SBR $97,974,633.00
  • Revenue This Year
  • IRON N/A
  • SBR N/A
  • Revenue Next Year
  • IRON N/A
  • SBR N/A
  • P/E Ratio
  • IRON N/A
  • SBR $10.06
  • Revenue Growth
  • IRON N/A
  • SBR 4.88
  • 52 Week Low
  • IRON $25.60
  • SBR $57.73
  • 52 Week High
  • IRON $77.60
  • SBR $69.50
  • Technical
  • Relative Strength Index (RSI)
  • IRON 37.45
  • SBR 59.52
  • Support Level
  • IRON $57.09
  • SBR $64.07
  • Resistance Level
  • IRON $62.20
  • SBR $66.50
  • Average True Range (ATR)
  • IRON 2.88
  • SBR 1.44
  • MACD
  • IRON -0.82
  • SBR 0.09
  • Stochastic Oscillator
  • IRON 8.16
  • SBR 96.93

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma and Texas.

Share on Social Networks: